28361121|t|A Systematic Review and Meta-Analysis of the Data Behind Current Recommendations for Corticosteroids in Non-HIV-Related PCP: Knowing When You Are on Shaky Foundations
28361121|a|Randomized trials show a mortality benefit to adjunctive corticosteroids for human immunodeficiency virus (HIV)-related Pneumocystis jiroveci pneumonia (HIV - PCP). Guidelines for non-HIV PCP (NH-PCP) recommend adjunctive corticosteroids based on expert opinion. We conducted a systematic review and meta-analysis characterizing adjunctive corticosteroids for NH-PCP. We searched MEDLINE from 1966 through 2015. Data on clinical outcomes from NH-PCP were extracted with a standardized instrument. Heterogeneity was assessed with the I(2) index. Pooled odds ratios and 95% confidence interval were calculated using a fixed effects model. Our search yielded 5044 abstracts, 277 articles were chosen for full review, and 6 articles described outcomes in moderate to severe NH-PCP. Studies were limited by variable definitions, treatment selection bias, concomitant infections and small sample size. Individual studies reported shorter intensive care unit stay and duration of mechanical ventilation of patients given adjunctive corticosteroids. There was no association between corticosteroids and survival in NH-PCP (odds ratio, 0.66; 95% confidence interval, 0.38-1.15; P = 0.14). The literature does not support an association between adjunctive corticosteroids and survival from NH-PCP but data are limited and findings should not be considered conclusive. Further research with improved methodology is needed to better understand the role of adjunctive corticosteroids for NH-PCP.
28361121	2	19	Systematic Review	T170	C1955832
28361121	24	37	Meta-Analysis	T170	C0282458
28361121	45	49	Data	T078	C1511726
28361121	65	80	Recommendations	T078	C0034866
28361121	85	100	Corticosteroids	T109,T121,T125	C0001617
28361121	104	123	Non-HIV-Related PCP	T047	C1535939
28361121	167	184	Randomized trials	T062,T170	C0206034
28361121	192	201	mortality	T081	C0205848
28361121	202	209	benefit	T081	C0814225
28361121	213	239	adjunctive corticosteroids	T109,T121,T125	C0001617
28361121	244	272	human immunodeficiency virus	T005	C0019682
28361121	274	277	HIV	T005	C0019682
28361121	287	318	Pneumocystis jiroveci pneumonia	T047	C1535939
28361121	320	323	HIV	T005	C0019682
28361121	326	329	PCP	T047	C1535939
28361121	332	342	Guidelines	T170	C0162791
28361121	347	358	non-HIV PCP	T047	C1535939
28361121	360	366	NH-PCP	T047	C1535939
28361121	378	404	adjunctive corticosteroids	T109,T121,T125	C0001617
28361121	414	428	expert opinion	T077	C0600219
28361121	445	462	systematic review	T170	C1955832
28361121	467	480	meta-analysis	T170	C0282458
28361121	496	522	adjunctive corticosteroids	T109,T121,T125	C0001617
28361121	527	533	NH-PCP	T047	C1535939
28361121	547	554	MEDLINE	T170	C0025141
28361121	579	583	Data	T078	C1511726
28361121	587	595	clinical	T080	C0205210
28361121	596	604	outcomes	T169	C1274040
28361121	610	616	NH-PCP	T047	C1535939
28361121	639	662	standardized instrument	T058	C1255665
28361121	664	677	Heterogeneity	T080	C0019409
28361121	700	710	I(2) index	T170	C0918012
28361121	719	730	odds ratios	T081	C0028873
28361121	739	758	confidence interval	T081	C0009667
28361121	783	802	fixed effects model	T081,T170	C0026348
28361121	828	837	abstracts	T170	C0600678
28361121	843	851	articles	T170	C0282420
28361121	857	863	chosen	T052	C1707391
28361121	873	879	review	T169	C0699752
28361121	887	895	articles	T170	C0282420
28361121	906	914	outcomes	T080	C0085415
28361121	937	943	NH-PCP	T047	C1535939
28361121	945	952	Studies	T062	C2603343
28361121	991	1000	treatment	T061	C0087111
28361121	1001	1015	selection bias	T081	C0036577
28361121	1017	1028	concomitant	T079	C0521115
28361121	1029	1039	infections	T046	C3714514
28361121	1044	1049	small	T081	C0700321
28361121	1050	1061	sample size	T081	C0242618
28361121	1063	1073	Individual	T098	C0237401
28361121	1074	1081	studies	T062	C2603343
28361121	1099	1118	intensive care unit	T073,T093	C0021708
28361121	1119	1123	stay	T079	C3489408
28361121	1128	1136	duration	T079	C0449238
28361121	1140	1162	mechanical ventilation	T061	C0199470
28361121	1166	1174	patients	T101	C0030705
28361121	1181	1207	adjunctive corticosteroids	T109,T121,T125	C0001617
28361121	1242	1257	corticosteroids	T109,T121,T125	C0001617
28361121	1262	1270	survival	T052	C0038952
28361121	1274	1280	NH-PCP	T047	C1535939
28361121	1282	1292	odds ratio	T081	C0028873
28361121	1304	1323	confidence interval	T081	C0009667
28361121	1351	1361	literature	T073,T170	C0034036
28361121	1402	1428	adjunctive corticosteroids	T109,T121,T125	C0001617
28361121	1433	1441	survival	T052	C0038952
28361121	1447	1453	NH-PCP	T047	C1535939
28361121	1458	1462	data	T078	C1511726
28361121	1467	1474	limited	T169	C0439801
28361121	1513	1523	conclusive	T080	C2828146
28361121	1533	1541	research	T062	C0035168
28361121	1556	1567	methodology	T078	C3266812
28361121	1611	1637	adjunctive corticosteroids	T109,T121,T125	C0001617
28361121	1642	1648	NH-PCP	T047	C1535939